MedPath
FDA Approval

Modafinil

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
December 12, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Modafinil(100 mg in 1 1)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

American Health Packaging

American Health Packaging

929561009

Products2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Modafinil

Product Details

NDC Product Code
68084-621
Application Number
ANDA202566
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
December 12, 2023
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48Class: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5XClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
POVIDONE K30Inactive
Code: U725QWY32XClass: IACT
ModafinilActive
Code: R3UK8X3U3DClass: ACTIBQuantity: 100 mg in 1 1

Modafinil

Product Details

NDC Product Code
68084-721
Application Number
ANDA202566
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
December 12, 2023
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48Class: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5XClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
ModafinilActive
Code: R3UK8X3U3DClass: ACTIBQuantity: 200 mg in 1 1
POVIDONE K30Inactive
Code: U725QWY32XClass: IACT
© Copyright 2025. All Rights Reserved by MedPath